Insulin Degludec (U-100) Prefilled Pens and Rituximab and Hyaluronidase
Determining the interaction of Insulin Degludec (U-100) Prefilled Pens and Rituximab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Prefilled Pens-Rituximab and hyaluronidase human, recombinant Subcutaneous
- Insulin Degludec (U-100) Prefilled Pens-Rituximab Intravenous
- Insulin Degludec (U-100) Prefilled Pens-Riva-Amoxicillin
- Insulin Degludec (U-100) Prefilled Pens-Rivaroxaban
- Insulin Degludec (U-100) Prefilled Pens-Rivastigmine
- Insulin Degludec (U-100) Prefilled Pens-Rivastigmine Capsules
- Rituximab and Hyaluronidase-Insulin Degludec (U-100) Vials
- Rituximab and Hyaluronidase-Insulin Degludec (U-200) Prefilled Pens
- Rituximab and Hyaluronidase-Insulin degludec and liraglutide
- Rituximab and Hyaluronidase-Insulin degludec and liraglutide Subcutaneous
- Rituximab and Hyaluronidase-Insulin degludec Subcutaneous
- Rituximab and Hyaluronidase-Insulin detemir